
Dr Kyle Matchett
Junior Council Member
Dr Kyle Matchett completed his PhD in October 2010 at Queen’s University Belfast (QUB). His thesis examined the expression of SEPT9 splice variants in ovarian tumours from the SCOTROC clinical trial and array CGH studies with the Institute of Cancer Research, London.
Following his PhD, Dr Matchett was appointed as a Cancer Research UK Postdoctoral Research Fellow at QUB. He discovered that estrogen metabolism is deregulated in BRCA1-deficient breast cells leading to increased production of estrogen metabolites and metabolite-induced DNA damage. Dr Matchett published his work in Cancer Research, and presented it at conferences in Montreal, London and Amsterdam. In recognition of this research, Dr Matchett was awarded the inaugural Professor John Fitzpatrick Prize by the Irish Association for Cancer Research (IACR).
Dr Matchett continued his interest in hormone signalling in breast cancer and moved to take up an EU FP7 Postdoctoral Research Fellow position focused on understanding the role of erythropoietin (EPO) in breast cancer. Based at QUB, his post involved collaboration and extensive travel with partner laboratories in Madrid, Innsbruck, Tel-Aviv, Vienna, Munich and Zurich. During this time, Dr Matchett played a key role in the development of novel EPO receptor antibodies with industrial partners Aldevron (Germany). He also led his own research which resulted in several publications.
In 2015, Dr Matchett was appointed as a Leukaemia and Leukaemia NI Postdoctoral Research Fellow following an increasing interest in haematology. His research focused on developing novel therapeutics for paediatric and adult acute myeloid leukaemia. This work has been recognised both nationally and internationally with a number of grants, invited talks and awards, including a presentation prize at XXXVI World Congress of the International Society of Haematology (2016), Little Princess Trust/Childhood Cancer and Leukaemia Group Project Grant Awards (2017, 2018) and a Novartis Fellowship Prize and Medal (2017).
In addition to his research programme, Dr Matchett completed his PGCHET in 2014 and was awarded a Fellowship of the Higher Education in 2015. He co-led a School-wide study examining postgraduate research student support, which was published in 2018.
Dr Matchett was appointed as a Lecturer at Ulster University in October 2018.
Dr Matchett was appointed onto the inaugural IACR Junior Council in 2015 and co-led a number of pioneering Junior Council initiatives including the Young Investigators Wednesday Night Session, Networking Session, and Irish Cancer Society-sponsored Media Training. He has co-authored three IACR meeting reports.
IACR Membership
We have a number of membership categories available. Find out which membership suits you.
IACR Virtual Conference 2021
Highlighting the spectrum of cancer science, medicine and research across the island of Ireland.
IACR Public Engagement
Would you like to know more about how we involve patients in research, our fundraising, and lay seminars?
Latest News
PhD in Tumour Immunology
A fully funded 4-year PhD studentship (€18,000 per annum stipend) is available in the research group of Dr. Aideen Ryan.
Education Grant 2020
The Irish Association for Cancer Research supported five Educational Grants in 2020. These were made available to postgraduate PhD researchers who had been affected by the Covid-19 pandemic.

Irish Association
for Cancer Research
9A Coolkill, Sandyford
Dublin 18, Ireland
D18 C1W3
info@iacr.ie
+353 (0)295 8859
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.
Registered Charity Number (RCN): 20030117.
©Design by LetterEleven